OMGAQ
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epig… Read more
OMGAQ (OMGAQ) - Total Liabilities
Latest total liabilities as of September 2024: $141.18 Million USD
Based on the latest financial reports, OMGAQ (OMGAQ) has total liabilities worth $141.18 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
OMGAQ - Total Liabilities Trend (2020–2023)
This chart illustrates how OMGAQ's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
OMGAQ Competitors by Total Liabilities
The table below lists competitors of OMGAQ ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MEDIOBANCA
BE:ME9
|
Germany | €87.98 Billion |
|
AMN HEALTHCARE (HCQ.SG)
STU:HCQ
|
Germany | €1.78 Billion |
|
MIZUNO
BE:MIZ
|
Germany | €58.14 Billion |
|
African Media Entertainment
JSE:AME
|
South Africa | ZAC132.29 Million |
Liability Composition Analysis (2020–2023)
This chart breaks down OMGAQ's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 12.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how OMGAQ's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for OMGAQ (2020–2023)
The table below shows the annual total liabilities of OMGAQ from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $146.35 Million | +265.63% |
| 2022-12-31 | $40.03 Million | +22.39% |
| 2021-12-31 | $32.70 Million | -64.72% |
| 2020-12-31 | $92.71 Million | -- |